Garrison Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,790
Closed -$200K 108
2018
Q3
$200K Buy
+4,790
New +$184K 0.1% 108
2015
Q2
Sell
-11,352
Closed -$375K 89
2015
Q1
$375K Sell
11,352
-378
-3% -$12K 0.25% 68
2014
Q4
$329K Hold
11,730
0.25% 68
2014
Q3
$329K Sell
11,730
-4,860
-29% -$136K 0.25% 68
2014
Q2
$467K Buy
16,590
+7,027
+73% +$200K 0.34% 60
2014
Q1
$291K Buy
9,563
+269
+3% +$8.02K 0.23% 66
2013
Q4
$270K Buy
9,294
+539
+6% +$15.7K 0.22% 65
2013
Q3
$239K Sell
8,755
-4,070
-32% -$111K 0.21% 68
2013
Q2
$341K Buy
+12,825
New +$354K 0.32% 57

Other funds holding PFE

Garrison Asset Management's PFE Position: Q4 2018 in Review

Garrison Asset Management sold out of Pfizer (PFE) in Q4 2018, closing a stake of 4,790 shares — an estimated $200K sold.

Garrison Asset Management first reported a position in PFE in Q2 2013 and held it in 9 quarters. The position peaked at $467K in Q2 2014. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

  • Garrison Asset Management reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
  • Garrison Asset Management sold 4,790 Pfizer shares in Q4 2018, an estimated $200K.
  • Garrison Asset Management first reported a position in Pfizer in Q2 2013 and held it in 9 quarters.
  • Garrison Asset Management's Pfizer position peaked at $467K in Q2 2014.
  • 2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Garrison Asset Management's 13F filing for Q4 2018, filed 5 Feb 2019.